E
Elevance Health Inc.
ELV · NYSE · USD
Historical Earnings
| Quarter | Reported | EPS est | EPS act | Surprise | Rev est | Rev act | Surprise | Reaction |
|---|---|---|---|---|---|---|---|---|
| Q3 2026 | Oct 21, 2026 | 4.71 | 6.99 | +48.4% | $49.2B | $50.4B | +2.5% | +2.57% |
| Q2 2026 | Jul 15, 2026 | 6.21 | 7.45 | +20.0% | $48.9B | $49.8B | +1.9% | −4.48% |
| Q1 2026 | Apr 22, 2026 | 10.82 | 12.58 | +16.3% | $48.2B | $49.5B | +2.7% | +5.51% |
| Q4 2025 | Jan 28, 2026 | 3.10 | 3.33 | +7.4% | $49.8B | $49.3B | −1.1% | +1.50% |
| Q3 2025 | Oct 21, 2025 | 4.93 | 6.03 | +22.3% | $49.4B | $50.1B | +1.4% | −1.30% |
| Q2 2025 | Jul 17, 2025 | 8.91 | 8.84 | −0.8% | $48.2B | $49.4B | +2.6% | −8.38% |
| Q1 2025 | Apr 22, 2025 | 11.41 | 11.97 | +4.9% | $46.3B | $48.8B | +5.3% | +2.64% |
| Q4 2024 | Jan 23, 2025 | 3.80 | 3.84 | +1.1% | $45.0B | $45.4B | +1.1% | −0.10% |
Detailed View
Q4 2026Jan 27, 2027Q3 2026Oct 21, 2026+2.57%Q2 2026Jul 15, 2026−4.48%Q1 2026Apr 22, 2026+5.51%Q4 2025Jan 28, 2026+1.50%Q3 2025Oct 21, 2025−1.30%Q2 2025Jul 17, 2025−8.38%Q1 2025Apr 22, 2025+2.64%Q4 2024Jan 23, 2025−0.10%Q3 2024Oct 17, 2024−3.06%Q2 2024Jul 17, 2024Q1 2024Apr 18, 2024
2026 Q3 Metrics
| Metric | Estimate | Actual | Surprise | Y/Y |
|---|---|---|---|---|
| Revenue | $49.2B | $50.4B | Beat +2.48% | +0.7% |
| EPS | 4.71 | 6.99 | Beat +48.41% | +15.9% |
| Diluted EPS (GAAP) | — | 6.27 | — | +17.9% |
Documents
- 8-K — Q3 20268-K · Sep 10, 2026 · sec.gov